BIOC Biocept Inc.

$-100%

726,249 Shares Traded
2,206,412 Average Volume (last 30 days)

as of February 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $837.41 thousand
If Intiated on the First, Shorts Have Realized a Year to Date Return of:60.71%
If Intiated One Month Ago, Shorts Have Realized a Return of:58.96%
If Initiated Five Days ago, Shorts Have Realized a Return of:11.15%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 4.33%
Short Interest2.93 million
Float67.51 million
Short Ratio1.41
Market Cap$18.71 million
Market Maker ActivityDaily Short Volume

News

02-05-2018
Biocept Receives Additional Patent Issuances in Three Major International Territories for its Target Selector Platform (PR Newswire)
01-30-2018
Biocept Announces Closing of $14.8 Million Public Offering of 32,854,606 Shares of Common Stock and Warrants to Purchase 32,854,606 Shares of Common Stock (PR Newswire)
01-30-2018
Biocept Comments on Updated Consensus Medical Guidelines Recommending Liquid Biopsy for Profiling of Tumor Biomarkers to Assist with the Treatment of Patients with Lung Cancer (PR Newswire)
01-26-2018
Your Daily Pharma Scoop: A Look At Advaxis, AstraZeneca's Positive Results, AbbVie Reports Q4 Results (SeekingAlpha)
01-26-2018
Biocept prices equity offering at $0.45; shares down 19% premarket (SeekingAlpha)
01-26-2018
Biocept Announces Pricing of $15.0 Million Public Offering of 33,333,333 Shares of Common Stock and Warrants to Purchase 33,333,333 Shares of Common Stock (PR Newswire)
01-09-2018
Biocept Study Shows Incorporation of Thermo Fisher QuantStudio 5 PCR Instrument into Target Selector Platform Improves Sensitivity and Specificity in Detection of Lung Cancer Biomarkers (PR Newswire)
01-04-2018
Biocept Obtains Patent in Australia for its Molecular Biomarker Technology For the Detection of Cancer-Associated Mutations in Blood, Tissue, and Other Biological Sources (PR Newswire)
12-18-2017
Biocept Signs In-Network Provider Agreement with Wellmark Blue Cross Blue Shield Expanding Coverage for its Target Selector Platform in Iowa and South Dakota (PR Newswire)
12-06-2017
Midday Gainers / Losers (SeekingAlpha)


Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 15.9%

Earnings Stats

PE Ratio -0.31
Dividend Yield 0%
Peer EarningsEarnings Calendar

Technicals

200 Day Moving Average $1.06
50 Day Moving Average $0.55
52 Week High $2.75
52 Week Low $0.26



Data provided for free by IEX. Questions? Read the FAQ